© Copyright Our Wall
Roots
Analysis is pleased to announce the publication of its recent study, titled,
“Monkeypox Market: Focus on Therapeutics, Vaccines and Diagnostic Kits,
2023-2035”
The
study features an extensive study of the current market landscape and future
opportunity for the players focused on the development of monkeypox
therapeutics, vaccines and diagnostic kits.
To request a sample copy / brochure
of this report, please visit
https://www.rootsanalysis.com/reports/monkeypox-treatment-market/request-sample.html
Amongst
other elements, the report features:
§ A general introduction to monkeypox virus, along with information on signs
and symptoms of the disease, history of monkeypox outbreaks and details on
transmission of disease from animals to humans and humans to humans.
§ A detailed assessment of the current
market landscape of monkeypox therapeutics / vaccines that are approved / under
development, based on several relevant parameters.
§ A detailed assessment of the current
market landscape of monkeypox
diagnostic kits,
based on several relevant parameters.
§ A product competitiveness analysis
of the monkeypox diagnostic kits, based on supplier power and product
competitiveness.
§ Elaborate profiles of prominent
players (shortlisted based on a proprietary criterion)engaged in monkeypox therapeutics / vaccines and diagnostic kits domain.
§ An analysis of the partnerships that
have been inked by stakeholders engaged in this domain, during the period
2018-2022 (till October).
§ An in-depth analysis on various
grants, received since the year 2003, by players engaged in this field.
§ A detailed analysis of more than 200
peer-reviewed, scientific articles related to research on monkeypox
therapeutics / vaccines and diagnostic kits, during the period of 2018-2022
(till September).
§ A qualitative analysis to understand
the five competitive forces under an insightful Porter's Five Forces framework.
§ More
than 165 diagnostic kits are currently available in the market for the
detection of monkeypox virus; these kits utilize various detection methods for monkeypox
diagnosis
§ Presently,
more than 25 therapeutics and vaccines are either marketed or under preclinical
/ clinical development for the treatment and prevention of monkeypox
disease.
§ A
detailed market forecast for monkeypox therapeutics / vaccines and diagnostic
kits, featuring analysis of the current and projected future opportunity across
key market segments (listed below):
§ Type of Product
§ Therapeutics
§ Vaccines
§ Developer
§ Bavarian
Nordic
§ Emergent
BioSolutions
§ KM
Biologics
§ SIGA
Technologies
§ Type
of Kit
§ Polymerase
Chain Reaction (PCR) Detection Kits
§ Antigen
Detection Kits
§ Antibody
Detection Kits
§ Type
of End User
§ Hospitals
and Clinics
§ Diagnostic
Laboratories
§ Other
End Users
§ Key
Geographical Regions
§ North America (US and Canada)
§ Europe (UK, France, Germany, Spain,
Italy, Rest of EU)
§ Asia-Pacific (Japan and Australia)
§ Rest of the World
§ Transcripts of interviews held with
the following senior level representatives of stakeholder companies:
§ Willy Tozoke Laou Man Cheong
(Business Director, Hunan Runmei Gene Technology)
§ John W Sharkey (Vice President,
Business Development, GeoVax)
§ Horace Lee (Sales Manager, Firegene)
§ Alan Yu (Sales Manager, Hangzhou
Testsea Biotechnology)
Key companies covered in the report
§ Bavarian Nordic
§ Emergent BioSolutions
§ ACON Laboratories
§ altona Diagnostics
§ DNA Software
§ Elabscience
§ Goldsite Diagnostics
§ Hangzhou Testsea Biotechnology
§ Jiangsu Bioperfectus Technologies
§ Lansion Biotechnology
For additional details, please visit https://www.rootsanalysis.com/reports/monkeypox-treatment-market.html
The Wall